GLP1 (glucagon like peptide 1) Receptor Agonist

[ jee-l-pee one a-guh-nuhst ]

A GLP-1 agonist is a type of medication used to treat Type 2 diabetes by mimicking the effects of a natural hormone in the body called glucagon-like peptide-1 (GLP-1). GLP-1 is produced in the intestine and helps to regulate blood sugar levels by stimulating insulin secretion and suppressing the production of glucagon, which is a hormone that raises blood sugar. GLP-1 also slows down the rate at which food is emptied from the stomach and reduces appetite.

GLP-1 agonists are injectable medications that are taken once a week or once a day, depending on the specific drug. They work by activating GLP-1 receptors in the body, which results in improved blood sugar control and a reduction in the risk of cardiovascular disease. GLP-1 agonists are often used in combination with other diabetes medications, such as metformin, to achieve optimal blood sugar control.